Connecticut Innovations
VC Fund
Rocky Hill, United States
Connecticut Innovations is a VC fund in Rocky Hill focused on Health Care and Biotechnology. [Connecticut Innovations](http://www.ctinnovations.com) provides strategic capital and operational insight to to companies in high-tech industries such as energy, biotechnology, information technology, and photonics. Their mission is to be the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. By offering flexible financing, strategic guidance and introductions to valuable partners, Connecticut innovations enable promising businesses to thrive.
- Total investments:
- 315
- Last investment:
- Lead investor:
- 30%
- Fund size:
- $50M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Connecticut Innovations invests in
Stages Connecticut Innovations invests in
Countries Connecticut Innovations invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 15 contacts → | |||
Round size
- Seed
- $150k–$5.3M
- Series A
- $1.8M–$25M
- Series B
- $1.8M–$75M
Investment Focus
Industry
- Health Care 73 (23%)
- Biotechnology 50 (16%)
- Software 43 (14%)
- Medical 32 (10%)
- Therapeutics 21 (7%)
Stage
- Seed 79 (25%)
- Series A 62 (20%)
- Series B 31 (10%)
- Venture - Series Unknown 30 (10%)
- Funding Round 20 (6%)
Country
- United States 192 (61%)
- Israel 9 (3%)
- Canada 4 (1%)
- India 3 (1%)
- Belgium 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alison Malloy
Managing Director, Investments
|
Managing Director, Investments | Total investments: 3 | Find email | |
|
Daniel Rappaport
Board of Directors
|
Board of Directors | Total investments: 2 | Find email | |
Matthew D. Storeygard
Managing Director, Venture Capital Investments
|
Managing Director, Venture Capital Investments | Total investments: 12 | Find email | |
| CEO | Total investments: 6 | Find email | ||
Dan Devine
Regenerative Medicine Research Fund Advisory Committee Member
|
Regenerative Medicine Research Fund Advisory Committee Member | Total investments: 0 | Find email | |
| See all 15 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Uvi provides infrastructure that serves as a context and reasoning layer for enterprise AI agents. The platform resolves internal corporate vocabulary, tracks dependencies, and reconstructs the decision-making intent scattered across disparate systems like Jira, GitHub, and Slack. By unifying data fragments into an integrated knowledge network, it enables AI tools to process query objectives accurately while enforcing existing user access permissions at the retrieval stage. | $7.5M / Seed / Oct 14, 2026 | ||
| LoopSmart AI is an enterprise-focused AI platform that provides AI agents for automating corporate activities, lowering operating expenses, and increasing productivity. | $3.5M / Seed / Oct 12, 2026 | ||
| UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. UltraSight won the TCT 2020Innovation Competition which took place during the Transcatheter Cardiovascular Therapeutics world conference. For mor information please visit us at www.ultrasight.com | $24M / Series B / Sep 23, 2026 | ||
| Queen One is creating innovative technology that, in a far more meaningful way than WeChat, texting, or email, links individuals with brands and brands with people. | $25M / Venture - Series Unknown / Aug 19, 2026 | ||
| Queen One is creating innovative technology that, in a far more meaningful way than WeChat, texting, or email, links individuals with brands and brands with people. | $2M / Seed / Aug 10, 2026 | ||
FAST Metals
|
FAST Metals is focused on developing innovative methods for the recovery and production of a range of valuable metals, including iron, aluminum, scandium, titanium, and rare earth elements. | $4.3M / Pre-Seed / Jul 29, 2026 | |
| Look Optic is a retail platform designed to make readers wear comfortable eyewear. The company's platform is based on lightweight glasses with blue light protection and ultra-lightweight matte frames that enable readers and consumers with better-quality glass.Founded in 2016 by Andrew Leary and Jonathan Saven, Look Optic is based in NewYork. | Series B / Jul 07, 2026 | ||
| Adaptive insurance, which begins with parametric insurance, seeks to transform how companies develop financial resilience in the face of weather-related and climate-related events. By combining our cutting-edge coverages, real-time climate data, and AI-driven technology, we think we can support them and show business consumers the benefits ofparametric insurance. | $5M / Seed / Jul 07, 2026 | ||
| Rejuvenate Bio is a biotechnology company that develops novel gene therapies for dogs. The company's therapy provides a solution for the mitral valve disease to stop the progression of heart failure in dogs, thus providing pets with extended overall health and maximal lifespan. It was founded in 2017 and is based in San Diego, CA. | $6M / Venture - Series Unknown / Jun 08, 2026 | ||
| Cypher AI is an AI-powered platform built for scientists that provides intelligent digital infrastructure for life sciences R&D, enabling research teams to create, organize, and share custom AI tools with zero coding required. This platform streamlines scientific workflows by automating data analysis, visualization, protocol generation, andrecording, turning messy lab scripts into shareable web apps. | $2M / Seed / May 27, 2026 | ||
| See all 315 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Connecticut Innovations invest in?
Connecticut Innovations invests primarily in Health Care, Biotechnology and Software startups, most often at Seed and Series A stage. Most of the 315 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Connecticut Innovations invest in?
Connecticut Innovations typically joins rounds of $150k–$5.3M at Seed, $1.8M–$25M at Series A and $1.8M–$75M at Series B. These are whole funding-round sizes, not Connecticut Innovations's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Connecticut Innovations took part in.
How do I contact Connecticut Innovations?
Public channels for Connecticut Innovations include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Connecticut Innovations?
The team at Connecticut Innovations includes Alison Malloy (Managing Director, Investments), Daniel Rappaport (Board of Directors) and Matthew D. Storeygard (Managing Director, Venture Capital Investments), among 15 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
